tiprankstipranks
Trending News
More News >
Ingevity (NGVT)
:NGVT
Advertisement

Ingevity (NGVT) AI Stock Analysis

Compare
222 Followers

Top Page

NGVT

Ingevity

(NYSE:NGVT)

Select Model
Select Model
Select Model
Neutral 48 (OpenAI - 4o)
Rating:48Neutral
Price Target:
$46.00
▼(-18.12% Downside)
Ingevity's overall stock score is primarily impacted by its financial performance challenges, including declining revenue and high leverage. Technical analysis indicates bearish momentum, further weighing on the score. Despite these challenges, the earnings call provided some positive insights, such as strategic divestitures and debt reduction, which offer potential for future improvement.
Positive Factors
EBITDA Margin Expansion
Consistent EBITDA margin expansion indicates strong operational efficiency and cost management, enhancing long-term profitability and competitiveness.
Debt Reduction
Reducing debt improves financial stability and flexibility, allowing Ingevity to invest in growth opportunities and weather economic downturns.
Strategic Divestiture
Divesting non-core assets allows Ingevity to focus on core segments, streamline operations, and strengthen its balance sheet.
Negative Factors
Declining Revenue
Declining revenue indicates potential loss of market share or demand, challenging Ingevity's ability to sustain growth and profitability.
High Leverage
High leverage increases financial risk, limiting Ingevity's ability to invest in growth and making it vulnerable to interest rate increases.
Profitability Challenges
Negative profit margins reflect operational inefficiencies and cost pressures, which could hinder long-term financial health and competitiveness.

Ingevity (NGVT) vs. SPDR S&P 500 ETF (SPY)

Ingevity Business Overview & Revenue Model

Company DescriptionIngevity Corporation (NGVT) is a global company specializing in advanced materials and specialty chemicals. It operates primarily in two segments: Performance Materials and Performance Chemicals. The company offers a range of products that include activated carbon, asphalt additives, and other chemical intermediates that cater to various industries such as automotive, construction, and consumer goods. Through innovative solutions and a commitment to sustainability, Ingevity aims to enhance performance and efficiency in its customers' applications.
How the Company Makes MoneyIngevity generates revenue through multiple key streams, primarily from the sale of its performance materials and chemicals. The Performance Chemicals segment contributes significantly by providing activated carbon and specialty additives used in air and water treatment, automotive, and industrial applications. The Performance Materials segment focuses on high-performance materials used in asphalt and adhesives, which are essential in construction and manufacturing industries. Additionally, Ingevity has established strategic partnerships with companies in automotive and construction sectors to develop tailored solutions, thus enhancing its market reach and driving sales. The company's commitment to innovation and sustainability also helps attract customers looking for environmentally friendly alternatives, further supporting its revenue growth.

Ingevity Earnings Call Summary

Earnings Call Date:Nov 05, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Feb 25, 2026
Earnings Call Sentiment Positive
The earnings call highlighted strategic progress with the divestiture of the Industrial Specialties business and strong performances in Performance Materials and Road Technologies. However, challenges in the APT segment and ongoing supply chain issues were noted. Overall, the positive highlights, such as debt reduction and margin expansion, outweighed the lowlights.
Q3-2025 Updates
Positive Updates
Strategic Divestiture Announcement
Ingevity announced the sale of its Industrial Specialties business for $110 million, expected to close in early 2026, with plans to use the majority of proceeds for debt reduction.
Performance Materials Growth
Performance Materials sales increased by 3% due to volume growth, despite a challenging global auto environment.
Record Sales in Road Technologies
The Road Technologies segment achieved record sales for its pavement business in North America, contributing to overall strong performance.
EBITDA Margin Expansion
Achieved best-in-class EBITDA margins of 33% for the sixth consecutive quarter of year-over-year margin expansion.
Debt Reduction and Share Repurchases
Strong cash flow enabled the company to reduce debt, achieving a net leverage of 2.7x ahead of the planned 2.8x target, and repurchased $25 million in shares.
Negative Updates
Sales Decline in APT Segment
Sales in APT declined year-over-year due to weak end market demand and competitive dynamics in China, with full-year revenue expected to be down by mid-teens percentage.
Impact of Tariffs and Supply Chain Issues
The indirect impact of tariffs and supply chain issues, including chip shortages, continued to affect the Performance Materials and APT segments.
Company Guidance
During the Ingevity Third Quarter 2025 Earnings Call, the company provided updated guidance reflecting strong financial performance and strategic initiatives. The company reported a sixth consecutive quarter of year-over-year adjusted EBITDA margin expansion, achieving best-in-class EBITDA margins of 33.5%. Total company sales were $362 million, down 4% due to decreases in Industrial Specialties and APT, despite increased sales in Performance Materials and Road Technologies. Adjusted earnings rose by almost 500 basis points to $56.3 million. Free cash flow reached $118 million, enabling $25 million in share repurchases and a reduction in net leverage to 2.7x, with expectations to reach 2.6x by year-end. The sale of the Industrial Specialties business for $110 million is expected to close by early 2026, with proceeds likely used for further debt reduction. Full-year revenue guidance for APT is projected to decline by mid-teens percentage, while Performance Materials revenue is expected to be flat to slightly down year-over-year with EBITDA margins over 50%. The company adjusted its full-year outlook, narrowing the top end of its sales and EBITDA range, and plans to host an investor update on December 8 to discuss strategic portfolio review results and future expectations.

Ingevity Financial Statement Overview

Summary
Ingevity faces significant financial challenges with declining revenue and profitability issues. High leverage poses financial risks, but strong free cash flow growth offers some relief. The company needs to address operational inefficiencies and improve its capital structure to enhance financial stability.
Income Statement
45
Neutral
Ingevity's income statement shows declining revenue with a negative growth rate of -3.31% TTM. The company has a negative net profit margin of -16.35% TTM, indicating significant profitability challenges. Gross profit margin is moderate at 36.47% TTM, but EBIT and EBITDA margins are negative, reflecting operational inefficiencies.
Balance Sheet
40
Negative
The balance sheet reveals high leverage with a debt-to-equity ratio of 11.02 TTM, indicating potential financial risk. The return on equity is negative, suggesting poor returns for shareholders. The equity ratio is low, highlighting a reliance on debt financing.
Cash Flow
55
Neutral
Cash flow analysis shows a strong free cash flow growth rate of 59.42% TTM, which is a positive indicator. However, the operating cash flow to net income ratio is 0.55, suggesting that cash generation is not fully supporting net income. The free cash flow to net income ratio is 0.70, indicating some level of cash flow sustainability.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.28B1.41B1.69B1.67B1.39B1.22B
Gross Profit487.10M454.70M471.90M570.10M512.80M465.50M
EBITDA143.30M-329.50M206.00M440.20M324.40M382.40M
Net Income-65.90M-430.30M-5.40M211.60M118.10M181.40M
Balance Sheet
Total Assets1.83B2.02B2.62B2.74B2.47B2.33B
Cash, Cash Equivalents and Short-Term Investments83.40M68.00M95.90M76.70M275.40M257.70M
Total Debt1.29B1.45B1.53B1.53B1.32B1.34B
Total Liabilities1.70B1.83B1.99B2.04B1.80B1.69B
Stockholders Equity138.10M195.20M631.40M698.30M673.80M642.10M
Cash Flow
Free Cash Flow239.60M51.00M95.30M170.60M189.20M246.50M
Operating Cash Flow298.60M128.60M205.10M313.10M293.00M352.40M
Investing Cash Flow-70.40M-79.50M-77.30M-553.90M-140.60M-110.60M
Financing Cash Flow-266.40M-70.20M-99.90M48.10M-133.10M-50.20M

Ingevity Technical Analysis

Technical Analysis Sentiment
Negative
Last Price56.18
Price Trends
50DMA
55.41
Negative
100DMA
51.95
Negative
200DMA
46.53
Positive
Market Momentum
MACD
-1.43
Positive
RSI
40.35
Neutral
STOCH
22.11
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NGVT, the sentiment is Negative. The current price of 56.18 is above the 20-day moving average (MA) of 54.00, above the 50-day MA of 55.41, and above the 200-day MA of 46.53, indicating a neutral trend. The MACD of -1.43 indicates Positive momentum. The RSI at 40.35 is Neutral, neither overbought nor oversold. The STOCH value of 22.11 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for NGVT.

Ingevity Risk Analysis

Ingevity disclosed 25 risk factors in its most recent earnings report. Ingevity reported the most risks in the "Ability to Sell" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Ingevity Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
62
Neutral
$1.73B-2,090.60-0.09%0.79%-2.53%-100.23%
62
Neutral
$979.86M21.923.67%3.49%5.35%-1.43%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
58
Neutral
$2.39B-0.64%1.42%0.08%-107.33%
54
Neutral
$2.29B-34.45%3.29%-13.67%
49
Neutral
$1.89B-0.09%2.13%-4.49%-100.80%
48
Neutral
$1.74B-38.91%-13.39%88.25%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
NGVT
Ingevity
49.86
2.36
4.97%
ASH
Ashland
49.89
-26.74
-34.89%
IOSP
Innospec
75.07
-47.32
-38.66%
MTX
Minerals Technologies
56.71
-25.59
-31.09%
KWR
Quaker Chemical
139.95
-30.36
-17.83%
SCL
Stepan Company
43.97
-33.52
-43.26%

Ingevity Corporate Events

Ingevity Corporation Reports Q3 2025 Financial Results
Nov 7, 2025

Ingevity Corporation, a global manufacturer of specialty chemicals and materials, operates in three segments: Performance Materials, Advanced Polymer Technologies, and Performance Chemicals, providing solutions for applications such as adhesives, agrochemicals, and automotive components.

Ingevity’s Earnings Call: Strategic Moves and Growth
Nov 7, 2025

Ingevity’s recent earnings call conveyed a generally positive sentiment, underscored by strategic advancements and robust performances in key segments. While the company acknowledged challenges, particularly in the APT segment and supply chain issues, the overall tone was optimistic, buoyed by debt reduction and margin expansion achievements.

Business Operations and StrategyExecutive/Board Changes
Ingevity Appoints Ruth Castillo as Senior VP
Positive
Oct 23, 2025

On October 23, 2025, Ingevity Corporation announced the appointment of Ruth Castillo as Senior Vice President and President of Performance Materials, effective November 10, 2025. Castillo, with over 25 years of experience in the chemicals and materials industries, will lead Ingevity’s activated carbon segment, focusing on innovation and strategic growth. Her leadership is expected to reinforce the segment’s market position in evaporative emissions control and expand into emerging applications, aligning with Ingevity’s goals for operational excellence and market-driven priorities.

The most recent analyst rating on (NGVT) stock is a Buy with a $69.00 price target. To see the full list of analyst forecasts on Ingevity stock, see the NGVT Stock Forecast page.

Business Operations and StrategyM&A Transactions
Ingevity Sells Refinery to Mainstream Pine for $110M
Positive
Sep 4, 2025

On September 4, 2025, Ingevity Corporation announced an agreement to sell its North Charleston crude tall oil refinery and the majority of its Industrial Specialties product line to Mainstream Pine Products for $110 million in cash, with potential additional contingent payments. This transaction aims to reduce portfolio volatility, strengthen Ingevity’s margin and cash flow profile, and enhance strategic flexibility. The sale is expected to close by early 2026 and will not impact Ingevity’s Road Technologies product line. The agreement includes various operational and supply arrangements between Ingevity and Mainstream, ensuring continuity and mutual benefits for both parties.

The most recent analyst rating on (NGVT) stock is a Hold with a $60.00 price target. To see the full list of analyst forecasts on Ingevity stock, see the NGVT Stock Forecast page.

Ingevity’s Financial Health at Risk Amid Escalating U.S.-China Tariff Tensions
Aug 7, 2025

Ingevity faces significant business risks due to recent changes in U.S. tariff policies, which have led to retaliatory tariffs from key trading partners like China. These developments are likely to increase the cost of exporting products and importing raw materials, potentially forcing Ingevity to raise prices, thereby reducing customer demand. The impact is expected to be particularly severe on the profitability of their Performance Materials and Performance Chemicals segments, as tariffs could lower margins and decrease demand for products incorporating Ingevity’s offerings. Consequently, these trade policy shifts could adversely affect Ingevity’s financial condition and operational results.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 07, 2025